scholarly journals Human brain glycogen content and metabolism: implications on its role in brain energy metabolism

2007 ◽  
Vol 292 (3) ◽  
pp. E946-E951 ◽  
Author(s):  
Gülin Öz ◽  
Elizabeth R. Seaquist ◽  
Anjali Kumar ◽  
Amy B. Criego ◽  
Luke E. Benedict ◽  
...  

The adult brain relies on glucose for its energy needs and stores it in the form of glycogen, primarily in astrocytes. Animal and culture studies indicate that brain glycogen may support neuronal function when the glucose supply from the blood is inadequate and/or during neuronal activation. However, the concentration of glycogen and rates of its metabolism in the human brain are unknown. We used in vivo localized 13C-NMR spectroscopy to measure glycogen content and turnover in the human brain. Nine healthy volunteers received intravenous infusions of [1-13C]glucose for durations ranging from 6 to 50 h, and brain glycogen labeling and washout were measured in the occipital lobe for up to 84 h. The labeling kinetics suggest that turnover is the main mechanism of label incorporation into brain glycogen. Upon fitting a model of glycogen metabolism to the time courses of newly synthesized glycogen, human brain glycogen content was estimated at ∼3.5 μmol/g, i.e., three- to fourfold higher than free glucose at euglycemia. Turnover of bulk brain glycogen occurred at a rate of 0.16 μmol·g−1·h−1, implying that complete turnover requires 3–5 days. Twenty minutes of visual stimulation ( n = 5) did not result in detectable glycogen utilization in the visual cortex, as judged from similar [13C]glycogen levels before and after stimulation. We conclude that the brain stores a substantial amount of glycogen relative to free glucose and metabolizes this store very slowly under normal physiology.

2011 ◽  
Vol 32 (2) ◽  
pp. 256-263 ◽  
Author(s):  
Gülin Öz ◽  
Nolawit Tesfaye ◽  
Anjali Kumar ◽  
Dinesh K Deelchand ◽  
Lynn E Eberly ◽  
...  

Supercompensated brain glycogen may contribute to the development of hypoglycemia unawareness in patients with type 1 diabetes by providing energy for the brain during periods of hypoglycemia. Our goal was to determine if brain glycogen content is elevated in patients with type 1 diabetes and hypoglycemia unawareness. We used in vivo13C nuclear magnetic resonance spectroscopy in conjunction with [1-13C]glucose administration in five patients with type 1 diabetes and hypoglycemia unawareness and five age-, gender-, and body mass index-matched healthy volunteers to measure brain glycogen content and metabolism. Glucose and insulin were administered intravenously over ∼51 hours at a rate titrated to maintain a blood glucose concentration of 7 mmol/L. 13C-glycogen levels in the occipital lobe were measured at ∼5, 8, 13, 23, 32, 37, and 50 hours, during label wash-in and wash-out. Newly synthesized glycogen levels were higher in controls than in patients ( P<0.0001) for matched average blood glucose and insulin levels, which may be due to higher brain glycogen content or faster turnover in controls. Metabolic modeling indicated lower brain glycogen content in patients than in controls ( P=0.07), implying that glycogen supercompensation does not contribute to the development of hypoglycemia unawareness in humans with type 1 diabetes.


Diabetes ◽  
2009 ◽  
Vol 58 (9) ◽  
pp. 1978-1985 ◽  
Author(s):  
G. Oz ◽  
A. Kumar ◽  
J. P. Rao ◽  
C. T. Kodl ◽  
L. Chow ◽  
...  

2003 ◽  
Vol 72 (1) ◽  
pp. 25-32 ◽  
Author(s):  
In-Young Choi ◽  
Elizabeth R. Seaquist ◽  
Rolf Gruetter

BIOPHYSICS ◽  
2020 ◽  
Vol 65 (1) ◽  
pp. 51-57
Author(s):  
A. Yakovlev ◽  
A. Manzhurtsev ◽  
P. Menshchikov ◽  
M. Ublinskiy ◽  
O. Bozhko ◽  
...  

1992 ◽  
Vol 70 (S1) ◽  
pp. S138-S144 ◽  
Author(s):  
Raymond A. Swanson

Brain glycogen is localized almost exclusively to glia, where it undergoes continuous utilization and resynthesis. We have shown that glycogen utilization increases during tactile stimulation of the rat face and vibrissae. Conversely, decreased neuronal activity during hibernation and anesthesia is accompanied by a marked increase in brain glycogen content. These observations support a link between neuronal activity and glial glycogen metabolism. The energetics of glycogen metabolism suggest that glial glycogen is mobilized to meet increased metabolic demands of glia rather than to serve as a substrate for neuronal activity. An advantage to the use of glycogen may be the potentially faster generation of ATP from glycogen than from glucose. Alternatively, glycogen could be utilized if glucose supply is transiently insufficient during the onset of increased metabolic activity. Brain glycogen may have a dynamic role as a buffer between the abrupt increases in focal metabolic demands that occur during normal brain activity and the compensatory changes in focal cerebral blood flow or oxidative metabolism.Key words: brain, glia, glycogen, glycolysis, hibernation.


2018 ◽  
Author(s):  
Shi-Lu Chen ◽  
Chris Zhiyi Zhang ◽  
Li-Li Liu ◽  
Shi-Xun Lu ◽  
Ying-Hua Pan ◽  
...  

AbstractHepatocarcinogenesis is attributed to the reprogramming of cellular metabolism as consequence of the alteration in metabolite-related gene regulation. Identifying the mechanism of aberrant metabolism is of great potential to provide novel targets for the treatment of hepatocellular carcinoma (HCC). Here, we demonstrated that glycogen synthase 2 (GYS2) restricted tumor growth in HBV-related HCC via a negative feedback loop with p53. Expression of GYS2 was significantly downregulated in HCC and correlated with decreased glycogen content and unfavorable patient outcomes. GYS2 overexpression suppressed, whereas GYS2 knockdown facilitated cell proliferation in vitro and tumor growth in vivo via modulating p53 expression. GYS2 competitively bound to MDM2 to prevent p53 from MDM2-mediated ubiquitination and degradation. Furthermore, GYS2 enhanced the p300-induced acetylation of p53 at K373/382, which in turn inhibited the transcription of GYS2 in the support of HBx/HDAC1 complex. In summary, our findings suggest that GYS2 serves as a prognostic factor and functions as a tumor suppressor in HCC. The newly identified HBx/GYS2/p53 axis is responsible for the deregulation of glycogen metabolism and represents a promising therapeutic target for the clinical management of HCC.SynopsisThis study elucidate the role of GYS2 in glycogen metabolism and the progression of HCC. The newly identified HBx/GYS2/p53 axis is responsible for the deregulation of glycogen metabolism and represents a promising therapeutic target for the clinical management of HCC.Decrease of GYS2 was significantly correlated with decreased glycogen content and unfavorable patient outcomes in a large cohort containing 768 patients with HCC.GYS2 overexpression suppressed, whereas GYS2 knockdown facilitated cell proliferation in vitro and tumor growth in vivo via modulating p53 signaling pathway.GYS2 competitively bound to MDM2 to prevent p53 from MDM2-mediated ubiquitination and degradation.GYS2 enhanced the p300-induced acetylation of p53 at Lys373/382, which in turn inhibited the transcription of GYS2 in the support of HBx/HDAC1 complex.


2021 ◽  
Vol 12 ◽  
Author(s):  
Guiyi Li ◽  
Alicia Hidalgo

The human brain can change throughout life as we learn, adapt and age. A balance between structural brain plasticity and homeostasis characterizes the healthy brain, and the breakdown of this balance accompanies brain tumors, psychiatric disorders, and neurodegenerative diseases. However, the link between circuit modifications, brain function, and behavior remains unclear. Importantly, the underlying molecular mechanisms are starting to be uncovered. The fruit-fly Drosophila is a very powerful model organism to discover molecular mechanisms and test them in vivo. There is abundant evidence that the Drosophila brain is plastic, and here we travel from the pioneering discoveries to recent findings and progress on molecular mechanisms. We pause on the recent discovery that, in the Drosophila central nervous system, Toll receptors—which bind neurotrophin ligands—regulate structural plasticity during development and in the adult brain. Through their topographic distribution across distinct brain modules and their ability to switch between alternative signaling outcomes, Tolls can enable the brain to translate experience into structural change. Intriguing similarities between Toll and mammalian Toll-like receptor function could reveal a further involvement in structural plasticity, degeneration, and disease in the human brain.


2004 ◽  
Vol 92 (1) ◽  
pp. 458-467 ◽  
Author(s):  
Rafael Kurtz

In motion-sensitive visual neurons of the fly, excitatory visual stimulation elicits Ca2+ accumulation in dendrites and presynaptic arborizations. Following the cessation of motion stimuli, decay time courses of the cytosolic Ca2+ concentration signals measured with fluorescent dyes were faster in fine arborizations compared with the main branches. When indicators with low Ca2+ affinity were used, the decay of the Ca2+ signals appeared slightly faster than with high affinity dyes, but the dependence of decay kinetics on branch size was preserved. The most parsimonious explanation for faster Ca2+ concentration decline in thin branches compared with thick ones is that the velocity of Ca2+ clearance is limited by transport mechanisms located in the outer membrane and is thus dependent on the neurite's surface-to-volume ratio. This interpretation was corroborated by UV flash photolysis of caged Ca2+ to systematically elicit spatially homogeneous step-like Ca2+ concentration increases of varying amplitude. Clearance of Ca2+ liberated by this method depended on branch size in the same way as Ca2+ accumulated during visual stimulation. Furthermore, the decay time courses of Ca2+ signals were only little affected by the amount of Ca2+ released by photolysis. Thus Ca2+ efflux via the outer membrane is likely to be the main reason for the spatial differences in Ca2+ clearance in visual motion-sensitive neurons of the fly.


ASN NEURO ◽  
2020 ◽  
Vol 12 ◽  
pp. 175909142097413
Author(s):  
Mostafa M. H. Ibrahim ◽  
Khaggeswar Bheemanapally ◽  
Paul W. Sylvester ◽  
Karen P. Briski

Norepinephrine (NE) control of hypothalamic gluco-regulation involves astrocyte-derived energy fuel supply. In male rats, exogenous NE regulates astrocyte glycogen metabolic enzyme expression in vivo through 5’-AMP-activated protein kinase (AMPK)-dependent mechanisms. Current research utilized a rat hypothalamic astrocyte primary culture model to investigate the premise that NE imposes sex-specific direct control of AMPK activity and glycogen mass and metabolism in these glia. In male rats, NE down-regulation of pAMPK correlates with decreased CaMMKB and increased PP1 expression, whereas noradrenergic augmentation of female astrocyte pAMPK may not involve these upstream regulators. NE concentration is a critical determinant of control of hypothalamic astrocyte glycogen enzyme expression, but efficacy varies between sexes. Data show sex variations in glycogen synthase expression and glycogen phosphorylase-brain and –muscle type dose-responsiveness to NE. Narrow dose-dependent NE augmentation of astrocyte glycogen content during energy homeostasis infers that NE maintains, over a broad exposure range, constancy of glycogen content despite possible changes in turnover. In male rats, beta1- and beta2-adrenergic receptor (AR) profiles displayed bi-directional responses to increasing NE doses; female astrocytes exhibited diminished beta1-AR content at low dose exposure, but enhanced beta2-AR expression at high NE dosages. Thus, graded variations in noradrenergic stimulation may modulate astrocyte receptivity to NE in vivo. Sex dimorphic NE regulation of hypothalamic astrocyte AMPK activation and glycogen metabolism may be mediated, in part, by one or more ARs characterized here by divergent sensitivity to this transmitter.


Sign in / Sign up

Export Citation Format

Share Document